Wellcome Trust Sanger Institute

Good News

3 Greeks behind the discovery of a novel, groundbreaking function of leukaemia cells

Kostas
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease. Researchers from the Wellcome Trust Sanger Institute, the Gurdon Institute and their collaborators show that inhibiting the METTL3...
Achievements

In search for novel biological pathways and therapies for AML

Kostas
Konstantinos Tzelepis is a Phd student at the Wellcome Trust Sanger Institute in Unicersity of Cambridge. He was born and raised in Peiraias, Greece. He studied Biomedical Sciences at TEI Athens and Human Neoplastic Disease (Cancer studies) in the Medical School of Athens. After his studies...
Good News

Greek researchers discovered the Achilles’ heel of leukemia

Kostas
[:el] Researchers from the Wellcome Trust Sanger Institute and their collaborators have adapted a CRISPR gene editing technique and used it to find new therapeutic targets for acute myeloid leukaemia (AML). In research published in Cell Reports, the team identify a large number of genes...
Achievements

Professor of Statistical Genetics at the Wellcome Trust Sanger Institute

Kostas
[:el] Eleftheria Zeggini is a Professor of Statistical Genetics at the Wellcome Trust Sanger Institute. Her research aims to identify novel complex trait loci by carrying out association studies, to develop analytical tools and to understand the molecular mechanisms underpinning disease pathogenesis. Zeggini was born...

Αυτός ο ιστότοπος χρησιμοποιεί cookies για να βελτιώσει την εμπειρία σας. Θα υποθέσουμε ότι είστε εντάξει με αυτό, αλλά μπορείτε να εξαιρεθείτε εάν το επιθυμείτε. ΑΠΟΔΟΧΗ Περισσότερα